Lack of mitogen-activated protein kinase phosphatase-1 protects ApoE-null mice against atherosclerosis

Circulation Research

Volumn 106, Issue 5, 2010, Pages 902-910

  Shen, Jianzhong ^a,b   Chandrasekharan, Unni M ^a   Ashraf, Mohammad Z ^a   Long, Eric ^a   Morton, Richard E ^a   Liu, Yusen ^c   Smith, Jonathan D ^a   DiCorleto, Paul E ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b AUBURN UNIVERSITY   (United States)

^c NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

Atherosclerosis; Cell migration; Macrophage; Mitogen activated protein kinases; Protein phosphatases

Indexed keywords

APOLIPOPROTEIN E; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; LIPID; MITOGEN ACTIVATED PROTEIN KINASE 10; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; STROMAL CELL DERIVED FACTOR 1; SYNAPTOPHYSIN; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; CXCL12 PROTEIN, MOUSE; DUSP1 PROTEIN, MOUSE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA ROOT; ARTICLE; ATHEROGENESIS; ATHEROMA; ATHEROSCLEROSIS; BODY WEIGHT; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; ENZYME DEFICIENCY; FEMALE; GENOTYPE; HEART INJURY; IMMUNOHISTOCHEMISTRY; LIPID BLOOD LEVEL; MACROPHAGE; MACROPHAGE MIGRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; STROMA CELL; WILD TYPE; AGING; ANIMAL; AORTA DISEASE; BLOOD; C57BL MOUSE; CELL MOTION; DISEASE MODEL; GENETICS; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHENOTYPE;

AGING; ANIMALS; AORTIC DISEASES; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BONE MARROW TRANSPLANTATION; CELL MOVEMENT; CHEMOKINE CXCL12; DISEASE MODELS, ANIMAL; DUAL SPECIFICITY PHOSPHATASE 1; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GENOTYPE; IMMUNOHISTOCHEMISTRY; INFLAMMATION MEDIATORS; INTERLEUKIN-10; INTERLEUKIN-1ALPHA; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIPIDS; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHENOTYPE; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77950884517     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.109.198069     Document Type: Article

References (32)

1. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med. 1999;340:115-126.
2. Libby P. Inflammation in atherosclerosis. Nature. 2002;420:868-874.
3. Senokuchi T, Matsumura T, Sakai M, Matsuo T, Yano M, Kiritoshi S, Sonoda K, Kukidome D, Nishikawa T, Araki E. Extracellular signalregulated kinase and p38 mitogen-activated protein kinase mediate macrophage proliferation induced by oxidized low-density lipoprotein. Atherosclerosis. 2004;176:233-245.
4. DiCorleto PE. Protein tyrosine phosphatases in the vessel wall: counterpoint to the tyrosine kinases. Arterioscler Thromb Vasc Biol. 2000;20:1179-1181.
5. Moorhead GB, Trinkle-Mulcahy L, Ulke-Lemée A. Emerging roles of nuclear protein phosphatases. Nat Rev Mol Cell Biol. 2007;8:234-244.
6. Alonso A, Sasin J, Bottini N, Friedberg I, Friedberg I, Osterman A, Godzik A, Hunter T, Dixon J, Mustelin T. Protein tyrosine phosphatases in the human genome. Cell. 2004;117:699-711. (Pubitemid 38748887)
7. Reddy S, Hama S, Grijalva V, Hassan K, Mottahedeh R, Hough G, Wadleigh DJ, Navab M, Fogelman AM. Mitogen-activated protein kinase phosphatase 1 activity is necessary for oxidized phospholipids to induce monocyte chemotactic activity in human aortic endothelial cells. J Biol Chem. 2001;276:17030-17035.
8. Reddy ST, Nguyen JT, Grijalva V, Hough G, Hama S, Navab M, Fogelman AM. Potential role for mitogen-activated protein kinase phosphatase-1 in the development of atherosclerotic lesions in mouse models. Arterioscler Thromb Vasc Biol. 2004;24:1676-1681.
9. Farooq A, Zhou MM. Structure and regulation of MAPK phosphatases. Cell Signal. 2004;16:769-779.
10. Dickinson RJ, Keyse SM. Diverse physiological functions for dualspecificity MAP kinase phosphatases. J Cell Sci. 2006;119:4607-4615.
11. Sun H, Charles CH, Lau LF, Tonks NK. MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo. Cell. 1993;75:487-493.
12. Keyse SM, Emslie EA. Oxidative stress and heat shock induce a human gene encoding a protein-tyrosine phosphatase. Nature. 1992;359:644-647.
13. Stawowy P, Goetze S, Margeta C, Fleck E, Graf K. LPS regulate ERK1/2-dependent signaling in cardiac fibroblasts via PKC-mediated MKP-1 induction. Biochem Biophys Res Commun. 2003;303:74-80.
14. Liu PQ, Lu W, Wang TH, Pan JY. MKP-1 regulates the cardiomyocyte hypertrophic responses induced by angiotensin II. Sheng Li Xue Bao. 2000;52:365-370.
15. Sugimoto T, Haneda M, Togawa M, Isono M, Shikano T, Araki S, Nakagawa T, Kashiwagi A, Guan KL, Kikkawa R. Atrial natriuretic peptide induces the expression of MKP-1, a mitogen-activated protein kinase phosphatase, in glomerular mesangial cells. J Biol Chem. 1996;271:544-547.
16. Chandrasekharan UM, Yang L, Walters A, Howe P, DiCorleto PE. Role of CL-100, a dual specificity phosphatase, in thrombin-induced endothelial cell activation. J Biol Chem. 2004;279:46678-46685.
17. Kinney CM, Chandrasekharan UM, Mavrakis L, DiCorleto PE. VEGF and thrombin induce MKP-1 through distinct signaling pathways: role for MKP-1 in endothelial cell migration. Am J Physiol Cell Physiol. 2008;294: C241-C250.
18. Wadgaonkar R, Pierce JW, Somnay K, Damico RL, Crow MT, Collins T, Garcia JG. Regulation of c-Jun. N-terminal kinase and p38 kinase pathways in endothelial cells. Am J Respir Cell Mol Biol. 2004;31:423-431.
19. Chi H, Barry SP, Roth RJ, Wu JJ, Jones EA, Bennett AM, Flavell RA. Dynamic regulation of pro-and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses. Proc Natl Acad Sci U S A. 2006;103:2274-2279.
20. Salojin KV, Owusu IB, Millerchip KA, Potter M, Platt KA, Oravecz T. Essential role of MAPK phosphatase-1 in the negative control of innate immune responses. J Immunol. 2006;176:1899-1907.
21. Zhao Q, Wang X, Nelin LD, Yao Y, Matta R, Manson ME, Baliga RS, Meng X, Smith CV, Bauer JA, Chang CH, Liu Y. MAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shock. J Exp Med. 2006;203:131-140.
22. Hammer M, Mages J, Dietrich H, Servatius A, Howells N, Cato AC, Lang R. Dual specificity phosphatase 1 (DUSP1) regulates a subset of LPS-induced genes and protects mice from lethal endotoxin shock. J Exp Med. 2006;203:15-20.
23. Wu JJ, Roth RJ, Anderson EJ, Hong EG, Lee MK, Choi CS, Neufer PD, Shulman GI, Kim JK, Bennett AM. Mice lacking MAP kinase phosphatase-1 have enhanced MAP kinase activity and resistance to diet-induced obesity. Cell Metab. 2006;4:61-73.
24. Baglione J, Smith JD. Quantitative assay for mouse atherosclerosis in the aortic root. Methods Mol Med. 2006;129:83-95.
25. Chandrasekharan UM, Mavrakis L, Bonfield TL, Smith JD, DiCorleto PE. Decreased atherosclerosis in mice deficient in tumor necrosis factor-alpha receptor-II (p75). Arterioscler Thromb Vasc Biol. 2007;27: e16-e17.
26. Garber DW, Kulkarni KR, Anantharamaiah GM. A sensitive and convenient method for lipoprotein profile analysis of individual mouse plasma samples. J Lipid Res. 2000;41:1020-1026.
27. Shen J, DiCorleto PE. ADP stimulates human endothelial cell migration via P2Y1 nucleotide receptor-mediated mitogen-activated protein kinase pathways. Circ Res. 2008;102:448-456.
28. Zakkar M, Chaudhury H, Sandvik G, Enesa K, Luong le A, Cuhlmann S, Mason JC, Krams R, Clark AR, Haskard DO, Evans PC. Increased endothelial mitogen-activated protein kinase phosphatase-1 expression suppresses proinflammatory activation at sites that are resistant to atherosclerosis. Circ Res. 2008;103:726-732.
29. VanderLaan PA, Reardon CA, Getz GS. Site specificity of atherosclerosis: site-selective responses to atherosclerotic modulators. Arterioscler Thromb Vasc Biol. 2004;24:12-22.
30. Damås JK, Waehre T, Yndestad A, Ueland T, Müller F, Eiken HG, Holm AM, Halvorsen B, Frøland SS, Gullestad L, Aukrust P. Stromal cellderived factor-1a in unstable angina: potential antiinflammatory and matrix-stabilizing effects. Circulation. 2002;106:36-42.
31. Zhang Y, Reynolds J, Chang SH, Martin-Orozco N, Chung Y, Nurieva RI, Dong C. MAP kinase phosphatase 1 is necessary for T cell activation and function. J Biol Chem. 2009;284:30815-30824.
32. Kinney CM, Chandrasekharan UM, Yang L, Shen J, Kinter M, McDermott MS, DiCorleto PE. Histone H3 as a novel substrate for MAP kinase phosphatase-1. Am J Physiol Cell Physiol. 2009;296: C242-C249.